{"log_id": 21989523889277632, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 0.000848, "average": 0.993019, "min": 0.831698}, "location": {"width": 669, "top": 215, "height": 41, "left": 245}, "words": "缓慢推送0.05ml注射液,应注意在之后的注射时改变巩膜注射部位"}, {"probability": {"variance": 2.4e-05, "average": 0.997492, "min": 0.974444}, "location": {"width": 743, "top": 277, "height": 40, "left": 245}, "words": "注射后必须监测患者的眼内压和眼内炎。监测应包括注射后立即检查视神经"}, {"probability": {"variance": 1e-06, "average": 0.999339, "min": 0.997104}, "location": {"width": 788, "top": 312, "height": 39, "left": 200}, "words": "乳头的血流灌流、30分钟内测眼内压及2~7天后进行检眼镜、裂隙灯和眼底检"}, {"probability": {"variance": 1e-06, "average": 0.999007, "min": 0.99604}, "location": {"width": 770, "top": 347, "height": 38, "left": 201}, "words": "查。需指导患者立即向其医生报告任何出现的眼内炎的症状(见【注意事项】"}, {"probability": {"variance": 6e-06, "average": 0.999061, "min": 0.987688}, "location": {"width": 743, "top": 408, "height": 38, "left": 247}, "words": "每支注射液仅用于治疗一只眼的单次注射。如果对侧眼也需要治疗,必须使"}, {"probability": {"variance": 2e-06, "average": 0.999094, "min": 0.993969}, "location": {"width": 788, "top": 441, "height": 41, "left": 200}, "words": "用新的一支注射液,并在向另一只眼注射本品前更换无菌区、注射器、手套、手"}, {"probability": {"variance": 3e-05, "average": 0.99742, "min": 0.980521}, "location": {"width": 251, "top": 484, "height": 30, "left": 203}, "words": "术单、开睑器和注射针头"}, {"probability": {"variance": 0, "average": 0.999521, "min": 0.998764}, "location": {"width": 142, "top": 547, "height": 28, "left": 200}, "words": "特殊人群用药"}, {"probability": {"variance": 2.9e-05, "average": 0.995236, "min": 0.987643}, "location": {"width": 72, "top": 609, "height": 27, "left": 204}, "words": "肾损害"}, {"probability": {"variance": 6e-06, "average": 0.998536, "min": 0.988819}, "location": {"width": 513, "top": 662, "height": 36, "left": 246}, "words": "肾损害患者无需调整用药剂量(见【药代动力学】)"}, {"probability": {"variance": 3e-06, "average": 0.997402, "min": 0.994774}, "location": {"width": 72, "top": 730, "height": 27, "left": 204}, "words": "肝损害"}, {"probability": {"variance": 5e-06, "average": 0.998367, "min": 0.991485}, "location": {"width": 618, "top": 784, "height": 37, "left": 246}, "words": "尚无相关研究。由于全身暴露可忽略不计,无须采取特别措施"}, {"probability": {"variance": 5.2e-05, "average": 0.995553, "min": 0.978281}, "location": {"width": 263, "top": 852, "height": 29, "left": 206}, "words": "儿童与青少年(18岁以下"}, {"probability": {"variance": 9e-06, "average": 0.998552, "min": 0.985333}, "location": {"width": 615, "top": 904, "height": 38, "left": 248}, "words": "尚无相关的安全与有效性数据。不建议儿童与青少年使用本品"}, {"probability": {"variance": 0, "average": 0.999602, "min": 0.999117}, "location": {"width": 97, "top": 975, "height": 26, "left": 204}, "words": "老年患者"}, {"probability": {"variance": 1e-06, "average": 0.999427, "min": 0.997437}, "location": {"width": 140, "top": 1033, "height": 28, "left": 249}, "words": "无需调整剂量"}, {"probability": {"variance": 0, "average": 0.999577, "min": 0.998793}, "location": {"width": 127, "top": 1094, "height": 29, "left": 209}, "words": "【不良反应】"}, {"probability": {"variance": 0.014336, "average": 0.890073, "min": 0.723573}, "location": {"width": 206, "top": 1087, "height": 75, "left": 826}, "words": " NA) PHARMACEUTIC"}, {"probability": {"variance": 0.029848, "average": 0.817003, "min": 0.578184}, "location": {"width": 144, "top": 1117, "height": 56, "left": 800}, "words": "人德士(中"}, {"probability": {"variance": 0.010849, "average": 0.966165, "min": 0.55443}, "location": {"width": 746, "top": 1144, "height": 42, "left": 249}, "words": "在三项Ⅲ期临床试验中共有1315名患者组成了安全性人群。所有患者接爱"}, {"probability": {"variance": 0.004478, "average": 0.982144, "min": 0.614075}, "location": {"width": 834, "top": 1174, "height": 55, "left": 204}, "words": "至少24个月的本品治疗。440名患者接受了0.5mg的推荐剂量的治跟公司"}, {"probability": {"variance": 0.000725, "average": 0.989899, "min": 0.880009}, "location": {"width": 718, "top": 1241, "height": 41, "left": 250}, "words": "以下严重不良事件与注射操作有关:眼内炎、孔源性视网膜脱离、视网膜"}, {"probability": {"variance": 5e-06, "average": 0.998688, "min": 0.990476}, "location": {"width": 432, "top": 1281, "height": 34, "left": 204}, "words": "裂和医源性外伤性白内障(见【注意事项】"}, {"probability": {"variance": 0.026736, "average": 0.864133, "min": 0.504989}, "location": {"width": 172, "top": 1280, "height": 66, "left": 708}, "words": "德士(中国)制药"}, {"probability": {"variance": 0.005372, "average": 0.984908, "min": 0.577189}, "location": {"width": 743, "top": 1336, "height": 41, "left": 250}, "words": "在接受本品治疗的患者观察到的其他严重眼部不良事件包括眼内炎症与眼"}, {"probability": {"variance": 7.5e-05, "average": 0.996124, "min": 0.972254}, "location": {"width": 296, "top": 1378, "height": 32, "left": 205}, "words": "内压升高(参见【注意事项】)"}, {"probability": {"variance": 0.002141, "average": 0.977711, "min": 0.753472}, "location": {"width": 742, "top": 1433, "height": 36, "left": 252}, "words": "在三项对照的ⅢI期试验FVF2598g( MARINA)、FVF2587g( ANCHOR)和"}, {"probability": {"variance": 0.001327, "average": 0.984341, "min": 0.798847}, "location": {"width": 788, "top": 1465, "height": 42, "left": 206}, "words": "FVF3192g(PIER)合并的数据中,以下列出的不良事件在0.5mg本品治疗组中的"}, {"probability": {"variance": 1e-05, "average": 0.997967, "min": 0.982596}, "location": {"width": 788, "top": 1500, "height": 39, "left": 206}, "words": "发生率(至少高出2个百分点)高于对照组(假注射治疗或维替泊芬光动力疗法"}], "language": 3}